Filing Details
- Accession Number:
- 0001232524-18-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-28 17:57:18
- Reporting Period:
- 2018-02-26
- Accepted Time:
- 2018-02-28 17:57:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601583 | P. Matthew Young | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2018-02-26 | 2,253 | $147.44 | 36,706 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2018-02-27 | 1,016 | $144.96 | 35,690 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-02-27 | 600 | $145.83 | 35,090 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-02-27 | 300 | $147.30 | 34,790 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-02-27 | 606 | $143.80 | 34,184 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2018-02-28 | 200 | $145.25 | 33,984 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-02-28 | 119 | $147.56 | 33,865 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-02-28 | 200 | $149.02 | 33,665 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2018-02-28 | 700 | $150.00 | 32,965 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.3100 to $145.2600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.4300 to $146.2700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.0600 to $147.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.0500 to $145.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.2200 to $147.6200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.6200 to $149.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
